7CE-21574-47688
4 vaccinations
8 coded responses
19 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 972 / OR
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-24
Dose 1 — Moderna
-
2021-02-18
Registered in v-safe
- 2021-02-18
-
2021-02-21
Dose 2 — Moderna
-
2021-02-21
Survey response — day 0, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Hypermobile Ehlers Danlos syndrome, Posteral Orthostatic Tachycardia Syndrome, mast cell activation syndrome, psoriasis, fibromyalgiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Hypermobile Ehlers Danlos Syndrome, postural Orthostatic Tachycardia Syndrome, mast cell activation syndrome, psoriasisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Ehlers-Danlos syndrome, Mast cell activation syndrome, Postural orthostatic tachycardia syndrome, Psoriasis — Feeling: Good · Muscle or body achesFree text: Hypermobile Ehlers Danlos syndrome, postural Orthostatic Tachycardia syndrome, mast cell activation syndrome, psoriasisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — days 1–6 daily, dose 2MedDRA: Ehlers-Danlos syndrome, Hypermobility syndrome, Mast cell activation syndrome, Postural orthostatic tachycardia syndrome, Pre-existing disease, Psoriasis — Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessFree text: Hypermobile Ehlers Danlos syndrome, postural Orthostatic Tachycardia syndrome, mast cell activation syndrome, psoriasisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Survey response — days 1–6 daily, dose 2MedDRA: Ehlers-Danlos syndrome, Mast cell activation syndrome, Psoriasis, Tachycardia — Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Hypermobile Ehlers Danlos syndrome, postural Orthostatic Tachycardia syndrome, mast cell activation syndrome, psoriasisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-27
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Headache · Be unable to do your normal daily activitiesFree text: Hypermobile Ehlers Danlos syndrome, postural Orthostatic Tachycardia syndrome, mast cell activation syndrome, psoriasisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-28
- 2021-03-07
-
2021-03-16
Survey response — day 21, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Hypermobile Ehlers Danlos syndrome, mast cell activation syndrome, postural Orthostatic tachycardia, psoriasis. All conditions and associated symptoms are (abnormally) worse since time of last check in.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-04-04
- 2021-05-25
- 2021-08-27
-
2021-11-03
Dose 3 — Moderna
- 2022-02-21
-
2022-05-24
Dose 4 — Moderna
-
2022-06-22
Survey response — day 28, dose 4MedDRA: Hypersensitivity, Neuropathy peripheral — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening whole body neuropathy following 4th dose (booster) to which I had an allergic reactionMedDRA releases: 2024-11 · check-in free text available
-
2022-06-22
Report sent to call center — day 28, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-23
- 2022-06-28
- 2022-07-05
- 2023-05-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-24 | Moderna | |
| 2 | 2021-02-21 | Moderna | |
| 3 | 2021-11-03 | Moderna | No |
| 4 | 2022-05-24 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — day 0, dose 2
Systemic reaction (other): Hypermobile Ehlers Danlos syndrome, Posteral Orthostatic Tachycardia Syndrome, mast cell activation syndrome, psoriasis, fibromyalgia
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Hypermobile Ehlers Danlos Syndrome, postural Orthostatic Tachycardia Syndrome, mast cell activation syndrome, psoriasis
Systemic reaction (other): Hypermobile Ehlers Danlos syndrome, postural Orthostatic Tachycardia syndrome, mast cell activation syndrome, psoriasis
Systemic reaction (other): Hypermobile Ehlers Danlos syndrome, postural Orthostatic Tachycardia syndrome, mast cell activation syndrome, psoriasis
Systemic reaction (other): Hypermobile Ehlers Danlos syndrome, postural Orthostatic Tachycardia syndrome, mast cell activation syndrome, psoriasis
Systemic reaction (other): Hypermobile Ehlers Danlos syndrome, postural Orthostatic Tachycardia syndrome, mast cell activation syndrome, psoriasis
Release 5 — day 21, dose 2
Symptoms: Hypermobile Ehlers Danlos syndrome, mast cell activation syndrome, postural Orthostatic tachycardia, psoriasis. All conditions and associated symptoms are (abnormally) worse since time of last check in.
Release 12 — day 28, dose 4
Symptoms: Worsening whole body neuropathy following 4th dose (booster) to which I had an allergic reaction
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Ehlers-Danlos syndrome | ✓ | ✓ | ✓ |
| SRO | Hypermobility syndrome | ✓ | ✓ | ✓ |
| SRO | Mast cell activation syndrome | ✓ | ✓ | ✓ |
| SRO | Postural orthostatic tachycardia syndrome | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Psoriasis | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release